Effects of Lithium Ions on tPA-Induced Hemorrhagic Transformation under Stroke

Thrombolytic therapy with the tissue plasminogen activator (tPA) is a therapeutic option for acute ischemic stroke. However, this approach is subject to several limitations, particularly the increased risk of hemorrhagic transformation (HT). Lithium salts show neuroprotective effects in stroke, but...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicines 2024-06, Vol.12 (6), p.1325
Hauptverfasser: Babenko, Valentina A, Yakupova, Elmira I, Pevzner, Irina B, Bocharnikov, Alexey D, Zorova, Ljubava D, Fedulova, Kseniya S, Grebenchikov, Oleg A, Kuzovlev, Artem N, Grechko, Andrey V, Silachev, Denis N, Rahimi-Moghaddam, Parvaneh, Plotnikov, Egor Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Thrombolytic therapy with the tissue plasminogen activator (tPA) is a therapeutic option for acute ischemic stroke. However, this approach is subject to several limitations, particularly the increased risk of hemorrhagic transformation (HT). Lithium salts show neuroprotective effects in stroke, but their effects on HT mechanisms are still unknown. In our study, we use the models of photothrombosis (PT)-induced brain ischemia and oxygen-glucose deprivation (OGD) to investigate the effect of Li on tPA-induced changes in brain and endothelial cell cultures. We found that tPA did not affect lesion volume or exacerbate neurological deficits but disrupted the blood-brain barrier. We demonstrate that poststroke treatment with Li improves neurological status and increases blood-brain barrier integrity after thrombolytic therapy. Under conditions of OGD, tPA treatment increased MMP-2/9 levels in endothelial cells, and preincubation with LiCl abolished this MMP activation. Moreover, we observed the effect of Li on glycolysis in tPA-treated endothelial cells, which we hypothesized to have an effect on MMP expression.
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines12061325